openPR Logo
Press release

Chronic Pain Treatment Market being Driven by Surging Geriatric Population | Top Key Players are Eli Lilly and Company, Pfizer, Medtronic, Boston Scientific, Johnson & Johnson, AstraZeneca, Bristol Myers Squibb, Sanofi

04-13-2020 12:50 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Chronic Pain Treatment Market being Driven by Surging Geriatric

In 2017, the global chronic pain treatment market reached a value of $69.3 billion and is expected to advance at a 6.4% CAGR during the forecast period (2019-2024). The market is registering growth due to the surging geriatric population, rising prevalence of chronic health conditions, and increasing government support for chronic pain management. The pain that persists in a patient beyond a period of three months is referred to as chronic pain. Chronic pain may limit mobility and reduce stamina, flexibility, and strength in patients.

Chronic Pain Treatment Market Key Players are:
1- Eli Lilly and Company
2- Pfizer
3- Medtronic
4- Boston Scientific
5- Johnson & Johnson
6- AstraZeneca
7- Bristol Myers Squibb
8- Sanofi

Download sample copy of this report@ http://bit.ly/2zm5Wgx

In terms of indication, the chronic pain treatment market is divided into arthritis pain, cancer pain, fibromyalgia, neuropathic pain, chronic back pain, migraine, and others (which include nociceptive pain and visceral pain). Among these, the neuropathic pain division dominated the market during the historical period (2014-2018) and is projected to grow at a 6.2% CAGR during the forecast period. The reason for this is the rising incidence of neuropathic disorders and surging aging population around the world. Cancer pain is predicted to grow at the fastest pace during the forecast period.

The increasing government support for chronic pain management is also among the primary driving factors of the chronic pain treatment market. The national and international government organizations have taken several initiatives in order to increase the awareness and funding for the effective management of chronic pain. For example, the Association for the Study of Pain (IASP) launched an IASP Developing Countries project in January 2018 for increasing pain education and practice in developing countries by providing sufficient grants.

Hence, the market is growing due to the increasing geriatric population, rising government support for chronic pain management, and surging prevalence of chronic health conditions across the globe.

Pre-Purchase Inquiry at@ https://bit.ly/34ynCmr

GLOBAL CHRONIC PAIN TREATMENT MARKET SEGMENTATION
By Product
o Drugs
o Opioids
o Non-steroidal anti-inflammatory drugs (NSAIDs)
o Anticonvulsants
o Antidepressants
o Others
o Devices
o Neurostimulation devices
? Spinal cord stimulation (SCS) devices
? Transcutaneous electrical nerve stimulation (TENS) devices
? Others
o Analgesic infusion pumps
o Ablation devices
? Radiofrequency ablation devices
? Cryoablation devices
o Others
By Indication
o Neuropathic Pain
o Arthritis Pain
o Chronic Back Pain
o Cancer Pain
o Migraine
o Fibromyalgia
o Others
By Application
o Musculoskeletal
o Neuropathy
o Oncology
o Others
By Distribution Channel
o Direct
o Indirect
By End User
o Hospitals
o Clinics
o Nursing Homes
o Research Centers and Universities
o Others

Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: http://psintelligence.blogspot.com

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Pain Treatment Market being Driven by Surging Geriatric Population | Top Key Players are Eli Lilly and Company, Pfizer, Medtronic, Boston Scientific, Johnson & Johnson, AstraZeneca, Bristol Myers Squibb, Sanofi here

News-ID: 2008112 • Views:

More Releases from P&S Intelligence

Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls
North America, the Largest Revenue Producer in Public Safety and Security Market
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and